Vitro SAB de CV Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

307.25

1,356.57

1,343.60

1,354.95

309.19

1,425.00

1,364.99

Other Operating Income

0.00

Total Operating income

307.25

1,356.57

1,343.60

1,354.95

309.19

1,425.00

1,364.99

Raw Material Cost

47.64

1,000.35

806.41

801.11

52.35

787.17

798.02

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

19.86

126.91

235.98

148.96

192.24

93.73

104.40

Selling and Distribution Expenses

307.95

488.48

438.59

460.95

331.95

670.13

473.07

Other Expenses

-1.99

-12.69

-23.60

-14.90

-19.22

-9.37

-10.44

Total Expenditure (Excl Depreciation)

355.59

1,488.82

1,244.99

1,262.06

384.30

1,457.30

1,271.10

Operating Profit (PBDIT) excl Other Income

-48.3

-132.3

98.6

92.89999999999999

-75.1

-32.3

93.9

Other Income

252.46

1,054.85

865.29

1,091.19

439.26

-447.35

-778.07

Operating Profit (PBDIT)

230.47

1,171.51

1,037.02

1,264.81

399.48

-403.66

-612.81

Interest

19.86

126.91

235.98

148.96

192.24

93.73

104.40

Exceptional Items

0.00

-2.25

2.32

-2.73

-2.51

-3.16

Gross Profit (PBDT)

259.61

356.22

537.19

553.83

256.84

637.84

566.97

Depreciation

26.36

248.92

73.13

80.74

35.33

75.98

71.37

Profit Before Tax

184.26

795.69

725.66

1,037.43

169.18

-575.88

-791.74

Tax

76.53

114.94

128.41

0.84

109.21

12.00

-29.72

Provisions and contingencies

0.00

Profit After Tax

107.73

562.97

642.01

1,058.58

59.96

-705.86

-652.28

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

107.73

562.97

642.01

1,058.58

59.96

-705.86

-652.28

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

107.73

562.97

642.01

1,058.58

59.96

-705.86

-652.28

Equity Capital

0.00

Face Value

0.0

Reserves

16,046.25

12,113.89

13,387.34

13,309.11

13,269.34

13,169.71

12,086.59

Earnings per share (EPS)

1.97

1.2

1.37

2.25

0.44

-1.5

-1.39

Diluted Earnings per share

1.97

1.2

1.37

2.25

0.44

-1.5

-1.39

Operating Profit Margin (Excl OI)

-15.73%

-9.75%

7.34%

6.86%

-24.29%

-2.27%

6.88%

Gross Profit Margin

68.55%

77.0%

59.45%

82.53%

66.14%

-35.08%

-52.78%

PAT Margin

35.06%

41.5%

47.78%

78.13%

19.39%

-49.53%

-47.79%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is -77.36% vs 0.97% in Dec 2025

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -80.87% vs -12.31% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -118.85% vs -32.03% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is -84.32% vs -46.23% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Vitro SAB de CV With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(MXN)

Change(%)

Net Sales

307.25

34,470.24

-34,162.99

-99.11%

Other Operating Income

0.00

Total Operating income

307.25

34,470.24

-34,162.99

-99.11%

Raw Material Cost

47.64

27,077.49

-27,029.85

-99.82%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

19.86

1,949.16

-1,929.30

-98.98%

Selling and Distribution Expenses

307.95

5,724.55

-5,416.60

-94.62%

Other Expenses

-1.99

-194.92

192.93

98.98%

Total Expenditure (Excl Depreciation)

355.59

32,802.04

-32,446.45

-98.92%

Operating Profit (PBDIT) excl Other Income

-48.34

1,668.20

-1,716.54

-102.90%

Other Income

252.46

263.40

-10.94

-4.15%

Operating Profit (PBDIT)

230.47

4,828.99

-4,598.52

-95.23%

Interest

19.86

1,949.16

-1,929.30

-98.98%

Exceptional Items

0.00

-87.80

87.80

100.00%

Gross Profit (PBDT)

259.61

7,392.75

-7,133.14

-96.49%

Depreciation

26.36

2,897.40

-2,871.04

-99.09%

Profit Before Tax

184.26

-105.36

289.62

274.89%

Tax

76.53

122.92

-46.39

-37.74%

Provisions and contingencies

0.00

Profit After Tax

107.73

-667.28

775.01

116.14%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

107.73

-667.28

775.01

116.14%

Share in Profit of Associates

0.00

Minority Interest

0.00

456.56

-456.56

-100.00%

Other related items

0.00

Consolidated Net Profit

107.73

-210.72

318.45

151.12%

Equity Capital

0.00

Face Value

0.00

Reserves

16,046.25

39,059.85

-23,013.60

-58.92%

Earnings per share (EPS)

1.97

-0.35

2.32

662.86%

Diluted Earnings per share

1.97

-0.35

2.32

662.86%

Operating Profit Margin (Excl OI)

-15.73%

4.84%

0.00

-20.57%

Gross Profit Margin

68.55%

8.10%

0.00

60.45%

PAT Margin

35.06%

-1.94%

0.00

37.00%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 30.72 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -77.36% vs 0.97% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -0.65% vs -74.49% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 10.77 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -80.87% vs -12.31% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 79.50% vs -86.53% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) -2.20 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -118.85% vs -32.03% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 44.72% vs -120.21% in Mar 2025

Quarterly - Interest

Interest 1.99 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -84.32% vs -46.23% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -89.65% vs 26.95% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) -15.73%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025